BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22080456)

  • 21. Cognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease.
    Castaneda AE; Tuulio-Henriksson A; Aronen ET; Marttunen M; Kolho KL
    World J Gastroenterol; 2013 Mar; 19(10):1611-7. PubMed ID: 23538788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family Support is Associated with Fewer Adherence Barriers and Greater Intent to Adhere to Oral Medications in Pediatric IBD.
    Feldman ECH; Durkin LK; Greenley RN
    J Pediatr Nurs; 2021; 60():58-64. PubMed ID: 33618177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emotional functioning, barriers, and medication adherence in pediatric transplant recipients.
    McCormick King ML; Mee LL; Gutiérrez-Colina AM; Eaton CK; Lee JL; Blount RL
    J Pediatr Psychol; 2014 Apr; 39(3):283-93. PubMed ID: 24080552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between disease activity, social support and health-related quality of life in patients with inflammatory bowel diseases: the mediating role of psychological symptoms.
    Fu H; Kaminga AC; Peng Y; Feng T; Wang T; Wu X; Yang T
    BMC Gastroenterol; 2020 Jan; 20(1):11. PubMed ID: 31937264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.
    Mittermaier C; Dejaco C; Waldhoer T; Oefferlbauer-Ernst A; Miehsler W; Beier M; Tillinger W; Gangl A; Moser G
    Psychosom Med; 2004; 66(1):79-84. PubMed ID: 14747641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions.
    Lenti MV; Selinger CP
    Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):215-226. PubMed ID: 28099821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depressive symptoms in youth with inflammatory bowel disease compared with a community sample.
    Reed-Knight B; Lobato D; Hagin S; McQuaid EL; Seifer R; Kopel SJ; Boergers J; Nassau JH; Suorsa K; Bancroft B; Shapiro J; Leleiko NS
    Inflamm Bowel Dis; 2014 Apr; 20(4):614-21. PubMed ID: 24518604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An exploration of family problem-solving and affective involvement as moderators between disease severity and depressive symptoms in adolescents with inflammatory bowel disease.
    Schuman SL; Graef DM; Janicke DM; Gray WN; Hommel KA
    J Clin Psychol Med Settings; 2013 Dec; 20(4):488-96. PubMed ID: 23793840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depression subtypes in pediatric inflammatory bowel disease.
    Szigethy EM; Youk AO; Benhayon D; Fairclough DL; Newara MC; Kirshner MA; Bujoreanu SI; Mrakotsky C; Bousvaros A; Srinath AI; Keljo DJ; Kupfer DJ; DeMaso DR
    J Pediatr Gastroenterol Nutr; 2014 May; 58(5):574-81. PubMed ID: 24345836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research.
    Trindade IA; Ferreira NB
    Inflamm Bowel Dis; 2021 Jul; 27(8):1224-1229. PubMed ID: 33043977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Combined Effects of Youth and Parent Illness Intrusiveness on Depressive Symptoms in Adolescents with Inflammatory Bowel Disease.
    Edwards CS; Roberts CM; Baudino MN; Basile NL; Gamwell KL; Jacobs NJ; Tung J; Grunow JE; Mullins LL; Chaney JM
    J Clin Psychol Med Settings; 2023 Mar; 30(1):238-247. PubMed ID: 35668287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors that modify therapy adherence in patients with inflammatory bowel disease.
    Bermejo F; López-San Román A; Algaba A; Guerra I; Valer P; García-Garzón S; Piqueras B; Villa C; Bermejo A; Rodríguez-Agulló JL
    J Crohns Colitis; 2010 Oct; 4(4):422-6. PubMed ID: 21122538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse.
    Hansen TM; Sabourin BC; Oketola B; Bernstein CN; Singh H; Targownik LE
    Inflamm Bowel Dis; 2020 Aug; 26(9):1401-1406. PubMed ID: 31725152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenting stress predicts depressive symptoms in adolescents with inflammatory bowel disease.
    Guilfoyle SM; Gray WN; Herzer-Maddux M; Hommel KA
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):964-71. PubMed ID: 25003746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression, anxiety, and loneliness among adolescents and young adults with IBD in the UK: the role of disease severity, age of onset, and embarrassment of the condition.
    Qualter P; Rouncefield-Swales A; Bray L; Blake L; Allen S; Probert C; Crook K; Carter B
    Qual Life Res; 2021 Feb; 30(2):497-506. PubMed ID: 32997335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The central role of psychopathology and its association with disease severity in inflammatory bowel disease and irritable bowel syndrome.
    Piacentino D; Cesarini M; Badiali D; Pallotta N; Biondi M; Corazziari ES
    Riv Psichiatr; 2019; 54(2):75-83. PubMed ID: 30985832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adolescents with inflammatory bowel disease: the roles of negative affectivity and hostility in subjective versus objective health.
    Ondersma SJ; Lumley MA; Corlis ME; Tojek TM; Tolia V
    J Pediatr Psychol; 1997 Oct; 22(5):723-38. PubMed ID: 9383932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease.
    Dempe C; Jünger J; Hoppe S; Katzenberger ML; Möltner A; Ladwig KH; Herzog W; Schultz JH
    J Psychosom Res; 2013 Feb; 74(2):122-7. PubMed ID: 23332526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Pilot Study Evaluating the Impact of an Adherence-promoting Intervention Among Nonadherent Youth With Inflammatory Bowel Disease.
    Maddux M; Ricks S; Delurgio S; Hommel K
    J Pediatr Nurs; 2017; 35():72-77. PubMed ID: 28728772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases.
    Stevens BW; Borren NZ; Velonias G; Conway G; Cleland T; Andrews E; Khalili H; Garber JG; Xavier RJ; Yajnik V; Ananthakrishnan AN
    Dig Dis Sci; 2017 Jan; 62(1):197-206. PubMed ID: 27796768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.